1Piro S,Maniscalchi ET,Monello A,et al.Palmitate affects insulin receptor phosphorylation and intracellular insulin signal in a pancreatic alphacell line[J] .Endocrinology,2010,151 (9):4197-4206.
2Kaneko K,Shirotani T,Araki E,et al.Insulin inhibits glucagon secretion by the activation of PI3-kinase in In-R1-G9 cells[J] .Diabetes Res Clin Pract,1999,44(2):83-92.
3Holst J J,Bersani M,Johnsen AH,et al.Proglucagon processing in porcine and human pancreas[J] .J Biol Chem,1994,269 (29):18827-18833.
4Unger RH.Role of glucagon in the pathogenesis of diabetes:the status of the controversy[J] .Metabolism,1978,27 (11):1691-1709.
5Ahren B,Larsson H.Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations[J] .Diabetologia,2001,44 (11):1998-2003.
6Buchanan KD,Mccarroll AM.Abnormalities of glucagon metabolism in untreated diabetes mellitus[J] .Lancet,1972,2 (7792):1394-1395.
7Larsson H,Ahren B.Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance[J] .Diabetes Care,2000,23 (5):650-657.
8Ahren B,Thorsson O.Increased insulin sensitivity is associated with reduced insulin and glucagon secretion and increased insulin clearance in man[J] .J Clin Endocrinol Metab,2003,88 (3):1264-1270.
9Ahren B.Glucagon secretion in relation to insulin sensitivity in healthy subjects[J] .Diabetologia,2006,49 (1):117-122.
10Asano T,Ninomiya H,Kan K,et al.Plasma glucagon response to intravenous alanine in obese and non-obese subjects[J] .Endocrinol Jpn,1989,36 (5):767-773.
8Aiaujo ER, Amaral ME, Souza CT, et al. Blockade of IRS-1 in isolated rat pancreatic islets improves glucose-induced insulin secretion. FEBS Lett, 2002,531:437-432.
9Kaneko K, Shirotani T, Araki E, et al. Insulin inhibits glucagon secretion by the activation of PI3-kinase in In-RI-G9 cells. Diabetes Res Clin Pract, 1999,44:83-92.
10Luo M, Li X, Li J, et al. Study on insulin receptor content and distribution of islet α cell in diabetic rats; preliminary insight into mechanism of pancreatic a cell insulin resistance. Diabetes, 2004,53 (Suppl 2) :A313.
4De Alwis NM, Day CP. Non-alcoholic fatty liver disease: The mist gradually clears[J]. J Hepatol,2008,48 (1) : S 104- S112.
5Jung DH,Shim JY,Lee HR,et al. Relationship between non-alcoholic fatty liver disease and pulmonary function[J]. Intern Med J,2012,42(5) :541-546.
6中国营养学会.中国居民膳食指南[M].拉萨:西藏人民出版社,2012:1-4.
7Ponugoti B,Kim DH,Xiao Z,et al. SIRT1 deacetylates and inhibits SREBP-lc activity in regulation of hepatic lipid metabolism[J]. J Biol Chem, 2010,285 (44) : 33959- 33970.
8Dentin R, Gigagd J,Postic C. Carbohydrate respon-sive element binding protein (ChREBP) and sterol regula- tory element binding protein-lc (SREBP-lc):Two key reg-ula tors of glucose metabolism and lipid synthesis in livers[J]. Biochimie, 2005,87 ( 1 ) : 81-86.
9Horton JD,Goldstein JL,Brown MS. SREBPs :activators of the complete program of cholesterol and fatty acid syn- thesis in the liver[J]. J Clin Invest, 2002,109 (2):1125- 1131.
10Kaneko K,Shirotani T,Araki E,et al. Insulin inhibits glucagon secretion by the activation of PI3-kinase in In- R1-G9 cells[J]. Diabetes Res Clin Pract, 1999,44(2): 83-92.
